Keimyung Medical Journal10.46308/kmj.2021.001152021402119-124Ruxolitinib for Treating Steroid-Refractory Acute Graft-Versus-Host Disease in an Infant with Malignant Osteopetrosis Who Received Double-Unit Umbilical Cord Blood TransplantationJie Hee Jue, Ye Jee Shim, Sung-Ae Kim, Hye Ra Jung,,
Biology of Blood and Marrow Transplantation10.1016/j.bbmt.2018.12.2622019253S258Safety Analysis of Patients Who Received Ruxolitinib for the Treatment of Steroid-Refractory Acute Graft-Vs-Host Disease in Expanded Access ProgramsMark A. Schroeder, Wael Toama, Mark A Fiala, Ahmad Naim, Amy Blithe, Dilan Paranagama, John F. DiPersio,
Biology of Blood and Marrow Transplantation10.1016/j.bbmt.2018.12.2602019253S257Ruxolitinib for Steroid-Refractory Acute Graft-Versus-Host DiseasWael Toama, Mark A Fiala, Iskra Pusic, Peter Westervelt, John F. DiPersio, Mark A. Schroeder,
Biology of Blood and Marrow Transplantation10.1016/j.bbmt.2018.12.2612019253S257-S258Ruxolitinib Treatment for Steroid Refractory ACUTE and Chronic GRAFT Versus Host Disease in Children: Clinical and Immunological ResultsMarta Gonzalez Vicent, Blanca Molina, Jesus Gonzalez de Pablo, Ana Castillo, Miguel Angel Diaz,
Biology of Blood and Marrow Transplantation10.1016/j.bbmt.2013.11.0122014202146-148Steroid-Refractory Acute Graft-versus-Host Disease: Is There an Effective Therapy?Joseph H. Antin,
Biology of Blood and Marrow Transplantation10.1016/j.bbmt.2010.12.5772011172S347Etanercept for Steroid-Refractory Acute Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell TransplantationJ.S. Park, S.H. Jeong, M.S. Ahn,
Biology of Blood and Marrow Transplantation10.1016/j.bbmt.2011.12.4452012182S370Bortezomib for Steroid Refractory Acute Graft Versus Host Disease (GVHD)J.L. Wagner, B. Mookerjee, J.E. Filicko-O'Hara, D.A. Grosso, N. Flomenberg,
Biology of Blood and Marrow Transplantation10.1016/j.bbmt.2010.06.012201016121747-1748Role of Extracorporeal Photopheresis (ECP) in Treatment of Steroid-Refractory Acute Graft-versus-Host DiseaseHildegard T. Greinix, Nina Worel, Robert Knobler,
Biology of Blood and Marrow Transplantation10.1016/j.bbmt.2017.12.1642018243S201Vedolizumab for Treatment of Steroid-Refractory Lower Gastrointestinal Acute Graft-Versus-Host Disease—a Quality InitiativeAlexander Coltoff, Guido Lancman, Sara Kim, Amir Steinberg,
Pediatric Transplantation10.1111/petr.125362015196582-583Revisiting mycophenolate mofetil for steroid-refractory acute graft-versus-host disease: Is higher dosing effective in children?John E. Levine,